On March 20, 2020, we conducted a very important Facebook Live broadcast, discussing what is known about coronavirus (COVID-19) and its implications for people living with multiple sclerosis. The opportunity...

We hate to state the obvious but... A while ago a study was published that showed that one of the main causes of fatigue in people living with multiple sclerosis was difficulty sleeping. Upon sharing these...

On March 5, 2020, Brett Drummond (Co-Founder of MStranslate and Chief Science Communicator) held a Facebook Live event to explain and discuss one of the most important topics in multiple sclerosis research,...

“Friendship is born at that moment when one person says to another: ‘What! You too? I thought I was the only one.” - C.S Lewis Two of the most common feelings that we hear from people living...

EXCLUSIVE INTERVIEW At ECTRIMS Congress 2019, we had the privilege of interviewing Prof. Dimitrios Karussis (Neurologist, Hadassah Hospital) about the exciting results from his mesenchymal stem cell trial...

Over recent years, we have seen a large expansion in the number of available treatments for people living with relapsing-remitting multiple sclerosis (RRMS).  As well as this, we have recently seen a number...

On December 4, 2019, Brett Drummond (Co-Founder of MStranslate and Chief Science Communicator) held a Facebook Live event to explain and discuss a number of recent important developments in multiple sclerosis...

In April 2018, we published the below video to our Facebook page, exploring and discussing the results of the Phase III trial of Mayzent (siponimod). With this therapy recently approved for the treatment of...

On a recent visit to Melbourne, Australia, Prof Amit Bar-Or (University of Pennsylvania) sat down with Prof Trevor Kilpatrick (University of Melbourne, Florey Institute of Neuroscience and Mental Health) to...

...